MS1819
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Entero Therapeutics
Overview
MS1819 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
MS1819 clinical trials
Explore related
Medical disclaimer. This page summarizes research about MS1819 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.